CAM inhibitors (Tanabe)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameCAM inhibitors (Tanabe)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell adhesion molecules inhibitors
TargetsCell adhesion molecules
Therapy Area/IndicationsAutoimmune DiseasesCardiovascular DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTanabe Seiyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUpjohn Pharmaceuticals IncTanabe Seiyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesCardiovascular DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A